Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Addition: Revision: v3.4.2 is now active; the previous government funding lapse notice (v3.4.1) has been removed, reflecting administrative site-wide updates rather than study data changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:46:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a government funding notice stating information may not be up to date and directing users to status updates. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:57:19.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Show glossary by default and minor labeling changes (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:16:06.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study data, eligibility criteria, or locations observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:36:28.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Locations section added with California sites; California locations list updated under v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:33:28.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page, with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:42:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.